July 20, 2010

Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System: A Population-Based Study

.   .   

This case control study suggests that older patients taking ACEIs or ARBs have a major increase in the risk of hyperkalemia-associated hospitalization when using trimethoprim-sulfamethoxazole.

Related Articles:

Chronic Kidney Disease, Fluid & Electrolytes, RAS Blockade
  • jack ditlove

    creatinine changes in those w/ hyperkalemia?